ORTEXORTEX News
Tracking MLKN? Get live short interest, options flow, and signals on ORTEX.Sign up free →
ML
Trader NoteMLKN

StoneX Upgrade Puts MillerKnoll Bulls Back in Charge

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 4 min readdata as of 21 Oct 2026, 18:42

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

MLKN enters the final stretch of October with a fresh upgrade from StoneX lifting analyst sentiment, even as the stock drifted about 1% lower on the week to $21.27. The tension is straightforward: the Street has just turned more constructive, the short position is quietly shrinking, and yet the stock is still trading at less than 70 cents on the dollar relative to the analyst's new $30 target.

The most meaningful data point of the past fortnight is the StoneX upgrade. On October 6, analyst Reuben Garner moved MillerKnoll from Hold to Buy and set a $30 price target, implying roughly 41% upside from current levels. That leaves the consensus firmly in buy territory, with two covering analysts both positive and a mean target of $31.50. The only other recent action worth noting is a Craig-Hallum target raise to $25 in September 2023, which is now too dated to carry much weight. The bulk of the analyst register predates the current price level significantly, so the StoneX move is, in practical terms, the lone fresh opinion on the stock.

Short positioning has been quietly retreating, and the lending market gives no sign of stress. Short interest at 5.4% of the free float is meaningful but not extreme, and it has fallen about 4.4% over the past month, unwinding some of the build seen in mid-September when shares shorted briefly approached the week's highs. Borrowing costs have dropped sharply, down 33% over 30 days to just 0.37%, a level that signals no particular urgency among short sellers to hold their positions. Availability is extremely loose, with around 56 million shares available to borrow against roughly 3.7 million currently shorted, giving an availability ratio near 1,100%. That combination, falling SI, cheap borrow, and ample supply, paints a picture of shorts trimming rather than pressing. The short score of 46.6 sits in the lower half of the universe and has been essentially flat all month, reinforcing that view.

Options positioning is broadly neutral with a mild defensive lean. The put/call ratio of 1.47 is almost exactly in line with the 20-day average of 1.49, so the z-score is negligible. There was a spike in put demand in late September when the PCR briefly hit 3.39, the 52-week high, but that has fully unwound. Current options flow neither confirms nor challenges the upgrade thesis.

One standout from the ORTEX Alt Data layer is worth noting. Retail attention has surged sharply, with the Wikipedia views signal registering a z-score of 6.4 against MillerKnoll's own prior 90-day history as of October 19. This measures the combined average of daily English Wikipedia views and ORTEX stock page visitors, and the current reading is well above anything seen in recent months. It is an attention signal only, not a revenue or earnings indicator, but a z-score at that level typically reflects a specific news catalyst driving search and page traffic rather than organic background interest. The StoneX upgrade filing on October 6 is the most obvious candidate.

Institutional ownership is concentrated and relatively stable. BlackRock holds 15.1% as reported through September 30, having added a modest 15,131 shares in the period. Dimensional Fund Advisors built a more notable position, adding about 285,000 shares to reach 5.2% of shares outstanding. Pzena Investment Management added over a million shares through June, though that data is now a quarter old. No 13D activists are on the register. The insider log shows only compensation-mechanics activity from August 1, grants and tax-withholding sales from a divisional president, with net insider transaction value at zero over the past 90 days. There is no open-market buying or selling from C-suite names to read into.

The alt-data buyback record is a minor negative flag. ORTEX data sourced from SEC EDGAR XBRL filings shows buyback spend fell 100% year-on-year in the April 2025 quarter, and spend has declined for three consecutive quarters. With the balance sheet clearly prioritising debt over returns of capital, the valuation multiple most relevant to watch is the price-to-earnings ratio, currently near 12.4x, which has risen about 0.9 points over the past 30 days as the stock recovered from its October lows. The EV/EBITDA of 9.2x is the only longer-term anchor in the data, though it is referenced against a June 2023 period and should be treated as ballpark context rather than a live reading.

The next earnings event falls on December 16. The three most recent prints produced one-day moves of plus 2.8%, minus 1.9%, and minus 1.4%, a pattern of modest volatility with no pattern of large directional beats. With the StoneX upgrade, retreating short interest, and elevated retail attention all arriving in the same week, the December print becomes the first real test of whether the new bull case on office furniture demand has any fundamental backing.

Stocks in this article

See the live data behind this article on ORTEX.

Open MLKN on ORTEX →

How this article was generated

Generated
21 Oct 2026, 18:46
Data as of
21 Oct 2026, 18:42
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.